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Cell cycle: Reaching for a role for the Cks proteins
Jonathon Pines
The Cks proteins are essential components of the
cyclin-dependent protein kinases that regulate mitosis
in all eukaryotes, but their precise function remains
obscure. The crystal structures of several Cks proteins
offer insights into their roles during the cell cycle.
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One of the most tantalizing questions in the control of the
cell cycle concerns the function of the Cks proteins. Why
tantalizing? Tantalus was punished by being forever
hungry and thirsty in a place where abundant fruit hung
overhead and cool water lapped at his feet. Yet when he
put out his hand, the fruit moved just out of reach, and
when he bent down, the water receded. This can be com-
pared to studying the Cks proteins: work on these proteins
has been intensive since their identification 10 years ago,
but what they do remains elusive. Furthermore, some
experiments indicate that the Cks proteins are required
for entry into mitosis, others implicate them only in exit
from mitosis, and still others in the control of transitions
between the G1 and S phases of the cycle and between
the G2 and M phases. The recently solved crystal struc-
tures of the Cks proteins alone [1–4], and of the human
CksHs1 as part of a binary complex with the cell-cycle
regulatory kinase Cdk2 [5], suggest that Cks proteins can
have two different conformations, one of which precludes
binding to the kinase. The structures also give clues to the
function of the Cks proteins in cell-cycle control.
The Cks family is composed of small proteins (9–18 kDa)
that perform essential, conserved functions in the cell cycle.
The first to be isolated was the product of suc1 [6], which is a
suppressor of defective alleles of cdc2, the gene encoding the
primary cyclin-dependent kinase (Cdk) in fission yeast. Sim-
ilarly, the homologous Cks in budding yeast was found by
virtue of its interaction with the budding yeast Cdk (Cdc28),
hence its designation as Cks1 (Cdc28 kinase subunit 1) [7].
The phenotypes of the two yeasts when CKS1 or suc1 is
deleted or overexpressed provide contradictory indications
of the protein’s role. Budding yeast with a defective Cks1p
[8] or fission yeast overexpressing Suc1 [9] arrest in G2
phase, whereas in the absence of Suc1 fission yeast enter
mitosis but arrest there with high levels of Cdc2 kinase
activity (see Fig. 1a) [10]. (Differences in phenotype
between the budding yeast temperature-sensitive mutation
and the fission yeast deletion strain might also be due to a
threshold effect, because the store of a stable protein gradu-
ally runs out in a deletion strain, whereas it is inactivated at
one point in time in a temperature-sensitive strain that is
shifted to the restrictive temperature.) Despite these differ-
ences, the two yeast proteins have been shown by comple-
mentation studies to be true homologues. Similarly, two
human homologues, CksHs1 and CksHs2, which were iso-
lated using the polymerase chain reaction [11], can each
functionally replace Cks1p in budding yeast.
A gene that suppresses a mutation in another gene often
does so because their encoded proteins bind to one another.
So it is for the Cks proteins and the cell-cycle regulatory
kinases. Co-immunoprecipitation studies have shown that
Cks proteins are bound to the mitotic cyclin-dependent
kinase in yeast [12], human cells [13] and frog eggs [14].
This conserved interaction underlies the widespread use of
Suc1 (p13suc1) as an affinity chromatography matrix to
purify cyclin–Cdk complexes from a variety of systems.
The Cks proteins have most often been implicated in mod-
ulating the tyrosine-phosphorylation state of the major
mitotic Cdk, the cyclin B–Cdc2 complex. Before mitosis,
cyclin B–Cdc2 is kept inactive by phosphorylation on Tyr 15
of the Cdc2 subunit. In cytoplasmic extracts of Xenopus eggs,
adding an excess of the Cks protein Xe-p9 correlates with a
delay in the tyrosine-dephosphorylation of the Cdc2 subunit
[14]. Immunodepleting a frog-egg extract of Xe-p9 has dif-
ferent effects depending on the stage of the cell cycle. Thus,
interphase extracts lacking Xe-p9 are unable to enter
mitosis, and they maintain Cdc2 in its Tyr 15-phosphory-
lated state (as do extracts with excess Xe-p9), whereas
mitotic extracts are unable to re-enter interphase, correlating
with a defect in cyclin B destruction [14]. This recapitulates
the phenotypes of Cks-deficient budding yeast (G2-phase
arrest) and fission yeast (M-phase arrest) — although the
G2-phase arrest in budding yeast is not likely to be due to a
defect in Cdc28 tyrosine-dephosphorylation, because this is
not required for the normal regulation of mitosis in the
budding yeast. But under some conditions budding yeast
with a defective Cks1p arrest in G2 phase without having
budded during the preceding G1 phase, and the one process
in the normal cell cycle in which Cdc28 tyrosine-phosphory-
lation has been shown to play a part is the coordination of
DNA replication with budding [15]. Thus, there is consider-
able circumstantial evidence linking the Cks proteins with
the regulation of Cdc2 tyrosine phosphorylation (Fig. 1b). Is
this borne out by the crystal structures?
The crystal structures of fission yeast Suc1 [1,3,4] and
human CksHs1 [16] and CksHs2 [2] have been solved.
These proteins can be crystallized in either of two forms: as
monomers or as strand-exchanged dimers (Fig. 2). Mono-
meric Cks proteins are composed of four anti-parallel b
sheets and two a helices (Fig. 2a), and for CksHs1 the
carboxy-terminal four-stranded b sheet bears a remarkable
resemblance to the amino-terminal lobe of a Cdk [16]. The
physiological significance of this is currently unknown, but
it is surely beyond coincidence. The key region involved in
determining how the Cks folds up is a b hinge, comprising
the residues HxPEPH (His–any–Pro–Glu–Pro–His) that
are conserved throughout the Cks family. When this region
folds back on itself the molecule forms a monomer, whereas
with an extended b hinge the proteins dimerize (Fig. 2b).
Cks proteins dimerize by exchanging b strands, an unusual
type of protein–protein interaction that has so far been seen
in only two other protein structures: seminal RNase and
diphtheria toxin [17,18].
Three strand-exchanged dimers can in turn oligmerize to
form a b barrel [2]. Although it is still unclear whether
this change in conformation is ever seen in vivo, it would
have dramatic consequences for the interaction between a
Cks molecule and a Cdk. This can be inferred from the
crystal structure of the binary Cdk2–CksHs1 complex,
recently solved by Bourne et al. [5] (Fig. 2c). In this struc-
ture, CksHs1 is in its monomeric form, with the b hinge
folded back on itself and forming important contacts with
the Cdk. Furthermore, molecular modelling predicts that
the Cks protein would be unable to bind to a Cdk when
the b hinge is extended [5]. This is because the His and
Glu residues of the Cks hinge region would be unable to
contact the Cdk, and other key hydrophobic residues
would be sequestered in an internal cavity of the dimer
[3], or an internal channel of the hexamer [2]. In addition,
the second subunit of the strand-exchanged dimer is pre-
dicted to be sterically hindered by the Cdk amino-termi-
nal lobe [5]. Thus it is a formal possibility that in the cell
there is an equilibrium between Cks monomers and
dimers, in which only the monomers are able to bind to a
Cdk. A change in this equilibrium would be predicted to
have an effect on the cyclin–Cdk complexes, but the con-
ditions that would alter the balance between monomers
and dimers in vivo are not clear; in vitro, crystallization as
dimers is favoured by the presence of Zn2+ [3,19].
Should the two forms of the Cks protein be able to inter-
change in vivo, this might allow for the intriguing possi-
bility of a cell-cycle regulated conformational change
from the monomer to the extended form. If this occurred
at the end of mitosis, for example, it might force the Cks
and Cdk to dissociate. In this regard it is interesting to
note that a prolyl isomerase, which could play a role in
altering the conformation of the b hinge, is essential for
exit from mitosis in yeast, and is able to associate with
another mitotic kinase, NimA, in a yeast two-hybrid
genetic interaction screen [20].
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(a) Summary of the effects of Cks deficiency or excess in different organisms. (b) The possible points during the cell cycle when Cks is required
(see text for details).
Aside from raising the possibility of regulation by oligomer-
ization, the crystal structures of the monomeric Cks and
the Cdk–Cks complex do suggest clues to Cks function.
The first feature to note is that the Cks subunit binds
exclusively to a continuous sequence of residues that form
a helix 5 and loop L14 at the carboxy-terminal lobe of the
Cdk [5], far away from the cyclin-interacting region [21].
This means that a trimeric complex of cyclin–Cdk–Cks is
perfectly feasible, in the case of either the G1 or the G2
cyclins in yeast — although it generates an as-yet unre-
solved question of why alanine-scanning mutagenesis
should have implicated residues in the amino-terminal
lobe of the Cdk as important for Cks binding [22].
In the budding yeast temperature-sensitive mutant Cdc28-
1N [23], the L14 loop has a non-conservative point muta-
tion in a conserved residue, Pro 250→Leu, which markedly
reduces binding to Cks1p in vitro [5]. Cdc28-1N mutant cells
arrest primarily in G2 phase, rather than in G1 phase like
most other Cdc28 mutants, indicating that the interaction
with Cks1 is especially important for the entry into mitosis
in budding yeast. However, two mutations in fission yeast
Cdc2 that map to this region give apparently contradictory
phenotypes. The DL50 Cdc2 mutant [24] has a deletion of
three amino acids (Leu–Gln–Asp, residues 240–242) and its
phenotype is a lethal, premature entry into mitosis. In the
crystal structure of Cdk2–CksHs1, the analogous residue to
Cdc2 Asp 242 (Cdk2 Asp 235) makes a strong hydrogen
bond via solvent to Glu 61, part of the hinge region of
CksHs1, so by analogy the DL50 mutation would be pre-
dicted to have a deleterious effect on the Cdc2–Suc1 inter-
action. In contrast to the premature mitotic entry
phenotype of DL50, a cold-sensitive mutant of Cdc2, in
which Asp 242 is altered to Asn, causes a block in G2 phase
and rescues the premature mitosis associated with overex-
pressing the Cdc25 phosphatase (which dephosphorylates
and activates Cdc2) in cells lacking the Wee1 kinase [25].
Together with the genetic and biochemical results, there-
fore, the crystal structures support the idea that the interac-
tion between the Cks proteins and Cdc2 (and perhaps the
resulting effect on Cdc2 tyrosine phosphorylation) is crucial
to passage through the G2–M-phase transition (see Fig. 1b).
The residues of loop L14 are evolutionarily conserved in the
mitotic Cdks and in a subset of human Cdks: Cdk1, Cdk2
and Cdk3, but not Cdk4, Cdk5 and Cdk6. Thus, in animal
cells, Cks proteins can only associate with a subset of the
G1-phase kinases — cyclin A–Cdk2 and cyclin E–Cdk2 —
explaining why affinity chromatography using Suc1 does not
purify D-type cyclin–Cdk4/6 complexes. The L14 loop also
has weak homology to a region in the MAP kinase family,
and indeed MAP kinase activity has been found to bind to
Suc1 affinity columns [26]. It is not clear, however, whether
the cyclin–Cdk complexes that are purified on a Suc1
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Figure 2
The crystal structures of CksHs1 as (a) a
monomer; (b) a strand-exchanged dimer; and
(c) in a complex with Cdk2. CksHs1 is shown
in yellow in all panels, and also in pink in (b)
as the second component of the strand-
exchanged dimer. The crucial residues that
make up the b hinge (His 60 and Glu 63) are
shown in their extended conformations in (b).
In (c) the amino-terminal lobe of Cdk2 is
shown in purple, and the carboxy-terminal
lobe is shown mostly in blue; the a5 helix and
L14 loop of Cdk2 that interacts with CksHs1
are shown in green. The T loop of Cdk2 is
shown in light mauve/grey with the
phosphorylated Thr 160 residue in orange;
ATP is also shown binding between the two
lobes. (Adapted from [5].)
column bind because they initially lack a Cks subunit, or
whether their original Cks subunit exchanges with the Suc1
on the column (the Cdk2–CksHs1 complex has a dissocia-
tion constant of 7.7 × 10–8 M), or whether more than one Cks
subunit can bind each cyclin–Cdk complex.
A model of the predicted cyclin–Cdk–Cks complex reveals
that the Cks would extend the site of interaction for a sub-
strate of the kinase [5]. The ATP-binding site of the Cdk
would be on the same side of the complex as a conserved,
positively charged pocket of the Cks subunit that has been
shown to bind the phosphate analogue, vanadate, in the
crystal structure of CksHs1 [16]. This raises the possibility
that the role of the Cks proteins is to target the cyclin–Cdk
complex to phosphoproteins. Given that different proteins
are phosphorylated at different times in the cell cycle, this
might account for the apparently contradictory nature of a
Cks deficiency in frog extracts and budding yeast com-
pared with fission yeast, as suggested by Patra and Dunphy
[14]. Thus, one phosphoprotein target in G2 phase could
be the Cdc25 phosphatase that activates the cyclin B–Cdc2
kinase and triggers entry into mitosis. In contrast, the
targets in mitosis might be phosphorylated components of
the cyclin proteolysis machinery that inactivate the cyclin
B–Cdc2 kinase and allow exit from mitosis. This still
doesn’t explain why adding excess Cks blocks Cdk
dephosphorylation, however. Speculative explanations
with no supporting data include: that more than one Cks
monomer is able to bind a cyclin–Cdk complex but that
this blocks access to phosphotyrosine 15 by the Cdc25
phosphatase; that excess Cks could drive the Cks equilib-
rium towards the strand-exchanged dimers that are unable
to bind the cyclin–Cdk complexes; or that excess Cks
protein could bind and sequester Cdc25.
The cyclin–Cdk–Cks model also has implications for the
phosphorylation of the T-loop threonine residue that is
required for full activation of the cyclin–Cdk complex.
Access to the T-loop threonine appears to be restricted in
the cyclin–Cdk–Cks complex, so there may be an order of
assembly and disassembly to forming an active cyclin–Cdk
complex. It may be that the T-loop threonine must be
phosphorylated (by the specific cyclin-activating kinase,
CAK) before the Cks is recruited, and that the T-loop
threonine can only be dephosphorylated (by the specific
phosphatase, KAP) after both the cyclin subunit has been
destroyed and the Cks subunit has dissociated.
Thus there is still considerable confusion over the function
of the Cks proteins, perhaps because of the apparent differ-
ences between organisms in the regulation of Cdk activity
through tyrosine phosphorylation. The Cks and Cdk–Cks
structures have gone some way towards suggesting what the
Cks proteins could do — supporting the idea that they
modulate interactions between Cdks and their regulators —
but what they actually do still remains just out of reach.
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